Odronic Shelley I, Maskovyak Amanda E, Springer Bridgette S, Dyhdalo Kathryn S, Abdul-Karim Fadi W, Booth Christine N
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
J Am Soc Cytopathol. 2014 Mar-Apr;3(2):79-85. doi: 10.1016/j.jasc.2013.09.003. Epub 2013 Oct 22.
Endobronchial ultrasonography (EBUS)-guided fine-needle aspiration (FNA) is increasingly used to sample central lung lesions and mediastinal lymphadenopathy. We investigate the utility of EBUS-guided FNA and concomitant rapid on-site evaluation (ROSE) to diagnose granulomas, the morphologic characteristics of granulomas on ROSE, and how the diagnosis of granulomas changed the clinical impression.
All pathologic reports and associated clinical records of patients who had EBUS-guided FNA of the lungs or mediastinal lymph nodes that yielded granulomas were reviewed with at least a 1-year follow-up after EBUS-guided FNA. All ROSE slides were rereviewed to evaluate granulomas for quantity, necrosis, and cohesion.
Over a 3-year period, 882 EBUS-guided FNAs were performed. One hundred and twelve patients (49% male, average age 50.8 years, range 16-83) had 161 EBUS-guided FNAs that yielded granulomas (18%). The etiologies of the granulomas were as follows: sarcoidosis (54%), infection (12%), malignancy (5%), inflammatory bowel disease-related lymphadenopathy (1%), and no specific clinical etiology (28%). Of the patients with EBUS-guided FNAs, 98 had ROSE performed (87.5%) and granulomas were seen in 70 of these patients (71%). Granulomas associated with sarcoidosis were mostly well-formed and non-necrotizing (90%). The results of the EBUS-guided FNA changed or redefined the clinical diagnosis in 79 patients (71%).
EBUS-guided FNA with concurrent ROSE is a useful technique for the diagnosis of granulomas. The quality and quantity of granulomas detected during ROSE may suggest an etiology and help direct ancillary testing.
支气管内超声(EBUS)引导下细针穿刺抽吸活检(FNA)越来越多地用于对中央型肺病变和纵隔淋巴结肿大进行取样。我们研究了EBUS引导下FNA及同步快速现场评估(ROSE)在诊断肉芽肿方面的效用、ROSE中肉芽肿的形态学特征,以及肉芽肿的诊断如何改变临床印象。
回顾了所有经EBUS引导对肺或纵隔淋巴结进行FNA并检出肉芽肿的患者的病理报告及相关临床记录,这些患者在EBUS引导下FNA后至少随访1年。重新检查所有ROSE玻片,以评估肉芽肿的数量、坏死情况和黏附性。
在3年期间,共进行了882次EBUS引导下FNA。112例患者(男性占49%,平均年龄50.8岁,范围16 - 83岁)接受了161次EBUS引导下FNA,结果检出肉芽肿(18%)。肉芽肿的病因如下:结节病(54%)、感染(12%)、恶性肿瘤(5%)、炎症性肠病相关淋巴结肿大(1%)以及无特定临床病因(28%)。在接受EBUS引导下FNA的患者中,98例进行了ROSE(87.5%),其中7 . 0例患者(71%)可见肉芽肿。与结节病相关的肉芽肿大多形态良好且无坏死(90%)。EBUS引导下FNA的结果改变或重新定义了79例患者(71%)的临床诊断。
EBUS引导下FNA联合ROSE是诊断肉芽肿的一种有用技术。ROSE期间检测到的肉芽肿的质量和数量可能提示病因,并有助于指导辅助检查。